Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regina Paleski

Set Alert for Articles By Regina Paleski

Latest From Regina Paleski

Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics

Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.

Appointments BioPharmaceutical

Executives On The Move: Global Aesthetics Head Exits Allergan for Merz, C-Level Commercial Changes at Flexion And Karyopharm

Merz Pharma Group’s Merz Aesthetics welcomes former Allergan exec as new chief scientific officer. Meanwhile, a chief commercial officer is appointed at Flexion Therapeutics, developer of treatments for musculoskeletal conditions, and at Karyopharm Therapeutics, an oncology-focused pharma.

Appointments BioPharmaceutical

Executives On The Move: UCB Announces Future Financial Leadership Change And Analytics Experience for Corbus Pharma

Corbus Pharmaceuticals, developer of therapeutics for inflammatory and fibrotic diseases, hires EMD Serono exec as head of commercial ops and analytics. Also, multinational biopharma UCB to have a new CFO in July.

Appointments BioPharmaceutical

Execs On The Move, March 2020

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Companies

Executives On The Move: Bayer Elects New Chairman, J&J Vision Exec Makes A Change for Eyevance And CureVac Decides On Candidate For Rare Diseases Post

Bayer AG elects a new chairman, to begin serving at the end of April. US ophthalmic products firm Eyevance Pharma brings on board a former J&J Vision exec as chief commercial officer, and German mRNA company CureVac AG appoints a new head of rare diseases.

Appointments BioPharmaceutical

Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex

T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.

Appointments BioPharmaceutical
See All
UsernamePublicRestriction

Register